4.7 Article

Takayasu Arteritis JACC Focus Seminar 3/4

Related references

Note: Only part of the references are listed.
Review Immunology

Therapeutic Management of Ocular Ischemia in Takayasu's Arteritis: A Case-Based Systematic Review

Yue Zeng et al.

Summary: The ocular outcomes after therapeutic management in Takayasu's arteritis (TA) remain largely unknown. A case-based systematic review found that surgical intervention might be a better choice for both acute and chronic vision loss, and surgery is recommended before the onset of irreversible ischemia to the globe.

FRONTIERS IN IMMUNOLOGY (2022)

Article Genetics & Heredity

Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study

Lourdes Ortiz-Fernandez et al.

Summary: A genetic study on Takayasu arteritis identified HLA risk factors and several susceptibility loci, shedding light on potential disease mechanisms. Comparison to other traits revealed genetic relatedness to inflammatory bowel disease, with epigenetic patterns suggesting roles for monocytes and B cells in Takayasu arteritis.

AMERICAN JOURNAL OF HUMAN GENETICS (2021)

Article Rheumatology

Revascularization Versus Medical Therapy in Takayasu's Arteritis Patients with Coronary Artery Involvement

Zhiwei Huang et al.

Summary: This study investigated the clinical characteristics and influence of revascularization versus medical therapy in TA patients with coronary artery involvement. Results showed no significant difference in cardiovascular death between medical treatment and revascularization, with higher restenosis rates in PCI compared to CABG. Heart failure was identified as an independent predictor of death in these patients.

RHEUMATOLOGY AND THERAPY (2021)

Article Cardiac & Cardiovascular Systems

Cardiovascular events and the role of accelerated atherosclerosis in systemic vasculitis

Alison H. Clifford et al.

Summary: The spectrum of inflammatory blood vessel diseases includes atherosclerosis and primary systemic vasculitides, with overlapping mechanisms contributing to sustained inflammation and vascular damage. Improved therapeutics for acute vasculitis have led to cardiovascular events becoming the leading cause of death for vasculitis patients. This is likely due to vascular damage from prior inflammation causing a sustained procoagulant state and accelerated atherosclerosis.

ATHEROSCLEROSIS (2021)

Review Rheumatology

Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis-a systematic review and meta-analysis

Durga Prasanna Misra et al.

Summary: The pharmacotherapy of Takayasu arteritis with DMARDs is evolving, with data from four RCTs and 63 observational studies. Current evidence has some bias, and more high-quality research is needed to guide the pharmacotherapy of TAK.

CLINICAL RHEUMATOLOGY (2021)

Review Rheumatology

Update on pregnancy in Takayasu arteritis-A narrative review

Shivraj Padiyar et al.

Summary: Takayasu arteritis is a chronic vasculitis that affects pregnant women and their babies, with conflicting data on fertility effects but generally unaffected outcomes. Disease activity of TA typically remains stable or decreases during pregnancy, but fetomaternal complications can still occur, highlighting the importance of controlling the disease before conception.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2021)

Review Rheumatology

Epidemiology of Takayasu arteritis in Shanghai: A hospital-based study and systematic review

Ying Sun et al.

Summary: This study estimated the prevalence and incidence of TAK in Shanghai, China, finding a higher prevalence and incidence in the 16-34 age group. The epidemiology of TAK varied greatly globally, with relatively higher rates in Asian countries. The disease burden of TAK differs across racial populations.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2021)

Article Rheumatology

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis

Mehrdad Maz et al.

Summary: This study provides evidence-based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK), addressing diagnostic testing, treatment, and management. The recommendations cover the use of diagnostic testing, treatments, and surgical interventions in GCA and TAK, with a focus on glucocorticoid-sparing immunosuppressive agents and nonglucocorticoid immunosuppressive agents.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Rheumatology

Clinical course of 602 patients with Takayasu's arteritis: comparison between Childhood-onset versus adult onset disease

Debashish Danda et al.

Summary: The clinical profile of Asian Indian patients with Takayasu's arteritis showed differences between childhood-onset and adult-onset cases, with childhood-onset patients more likely to have arterial involvement below the diaphragm and higher levels of systemic inflammation, leading to a greater likelihood of achieving remission.

RHEUMATOLOGY (2021)

Review Rheumatology

2018 Update of the EULAR recommendations for the management of large vessel vasculitis

Bernhard Hellmich et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

Article Multidisciplinary Sciences

Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis

Tomoyuki Mutoh et al.

NATURE COMMUNICATIONS (2020)

Article Rheumatology

Patterns of clinical presentation in Takayasu's arteritis

Kaitlin A. Quinn et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)

Review Rheumatology

Takayasu arteritis: advanced understanding is leading to new horizons

Enrico Tombetti et al.

RHEUMATOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Statins reduce relapse rate in Takayasu arteritis

Oh Chan Kwon et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)

Review Surgery

Endovascular Versus Open Surgical Intervention in Patients with Takayasu's Arteritis: A Meta-analysis

Jae Hyun Jung et al.

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2018)

Article Cardiac & Cardiovascular Systems

FDG Uptake by Prosthetic Arterial Grafts in Large Vessel Vasculitis Is Not Specific for Active Disease

Taryn Youngstein et al.

JACC-CARDIOVASCULAR IMAGING (2017)

Article Cardiac & Cardiovascular Systems

Selective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu arteritis: Two-year results

Meng Peng et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)

Article Rheumatology

Takayasu Arteritis and Pregnancy

C. Comarmond et al.

ARTHRITIS & RHEUMATOLOGY (2015)

Article Rheumatology

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

J. C. Jennette et al.

ARTHRITIS AND RHEUMATISM (2013)

Article Medicine, General & Internal

Diagnostic Features, Treatment, and Outcomes of Takayasu Arteritis in a US Cohort of 126 Patients

Jean Schmidt et al.

MAYO CLINIC PROCEEDINGS (2013)

Review Cardiac & Cardiovascular Systems

Pathology of Takayasu arteritis: A brief review

Pradeep Vaideeswar et al.

ANNALS OF PEDIATRIC CARDIOLOGY (2013)

Review Immunology

Pathogenesis of Takayasu's arteritis: A 2011 update

Laurent Arnaud et al.

AUTOIMMUNITY REVIEWS (2011)

Article Ophthalmology

OCULAR MANIFESTATIONS OF TAKAYASU ARTERITIS A Cross-Sectional Study

Jayanthi Peter et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)

Article Cardiac & Cardiovascular Systems

Antiplatelet Therapy for the Prevention of Arterial Ischemic Events in Takayasu Arteritis

Alexandre W. S. de Souza et al.

CIRCULATION JOURNAL (2010)

Article Cardiac & Cardiovascular Systems

Toll-Like Receptors 4 and 5 Induce Distinct Types of Vasculitis

Jiusheng Deng et al.

CIRCULATION RESEARCH (2009)

Article Rheumatology

The story of Takayasu arteritis

F Numano

RHEUMATOLOGY (2002)